BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25043296)

  • 1. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
    Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma.
    Yang R; Hoang BH; Kubo T; Kawano H; Chou A; Sowers R; Huvos AG; Meyers PA; Healey JH; Gorlick R
    Int J Cancer; 2007 Sep; 121(5):943-54. PubMed ID: 17410535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway.
    Liu X; Geng Z; Ding X; Lou Y; Zhang X
    Bioengineered; 2022 May; 13(5):13280-13292. PubMed ID: 35635031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways.
    Li S; Dong Y; Wang K; Wang Z; Zhang X
    J Orthop Surg Res; 2017 Nov; 12(1):168. PubMed ID: 29121993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells.
    Menuki K; Mori T; Sakai A; Sakuma M; Okimoto N; Shimizu Y; Kunugita N; Nakamura T
    Bone; 2008 Sep; 43(3):613-20. PubMed ID: 18567552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q; Yu H; Chen J; Song X; Sun L
    Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective.
    Sun C; Li S
    J Cell Mol Med; 2021 Apr; 25(7):3175-3181. PubMed ID: 33675132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Alanine mediated inhibition of PTHR1suppresses the proliferation, invasion and tumorigenesis in metastatic human osteosarcoma U2OS cells.
    Li S; Chen P; Zheng K; Wang W; Pei Y; Qiu E; Zhang X
    Int J Biol Macromol; 2018 May; 111():1255-1263. PubMed ID: 29366883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.
    Guan D; Tian H
    World J Surg Oncol; 2017 Sep; 15(1):177. PubMed ID: 28934958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
    Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
    Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein.
    Ansari N; Ho PW; Crimeen-Irwin B; Poulton IJ; Brunt AR; Forwood MR; Divieti Pajevic P; Gooi JH; Martin TJ; Sims NA
    J Bone Miner Res; 2018 Jan; 33(1):137-153. PubMed ID: 28914969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells.
    Song J; Zhang J; Shao J
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):263-9. PubMed ID: 26055549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review).
    Nikitovic D; Kavasi RM; Berdiaki A; Papachristou DJ; Tsiaoussis J; Spandidos DA; Tsatsakis AM; Tzanakakis GN
    Oncol Rep; 2016 Oct; 36(4):1787-92. PubMed ID: 27499459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
    Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of an element within the rat parathyroid hormone/parathyroid hormone-related peptide receptor gene promoter that enhances expression in osteoblastic osteosarcoma 17/2.8 cells.
    Giannoukos G; Williams LJ; Chilco PJ; Abou-Samra AB
    Biochem Biophys Res Commun; 1999 May; 258(2):336-40. PubMed ID: 10329388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma.
    Al-Khan AA; Nimmo JS; Tayebi M; Ryan SD; Simcock JO; Tarzi R; Kuntz CA; Saad ES; Day MJ; Richardson SJ; Danks JA
    Sci Rep; 2020 Jan; 10(1):1564. PubMed ID: 32005896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
    Ji T; Guo Y; Kim K; McQueen P; Ghaffar S; Christ A; Lin C; Eskander R; Zi X; Hoang BH
    Mol Cancer; 2015 Apr; 14():86. PubMed ID: 25890345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.